Patterns of somatic mutation in human cancer genomes C Greenman, P Stephens, R Smith, GL Dalgliesh, C Hunter, G Bignell, ... Nature 446 (7132), 153, 2007 | 3850 | 2007 |
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study DYC Heng, W Xie, MM Regan, LC Harshman, GA Bjarnason, ... The lancet oncology 14 (2), 141-148, 2013 | 1136 | 2013 |
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations MH Tan, JL Mester, J Ngeow, LA Rybicki, MS Orloff, C Eng Clinical Cancer Research 18 (2), 400-407, 2012 | 1075 | 2012 |
Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors H Li, ET Courtois, D Sengupta, Y Tan, KH Chen, JJL Goh, SL Kong, ... Nature genetics 49 (5), 708, 2017 | 1037 | 2017 |
An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma A Ooi, JC Wong, D Petillo, D Roossien, V Perrier-Trudova, D Whitten, ... Cancer Cell 20 (4), 511-523, 2011 | 439 | 2011 |
A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands MH Tan, J Mester, C Peterson, Y Yang, JL Chen, LA Rybicki, K Milas, ... The American Journal of Human Genetics 88 (1), 42-56, 2011 | 437 | 2011 |
Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study JH Ng, NG Iyer, MH Tan, G Edgren Head & neck 39 (2), 297-304, 2017 | 425 | 2017 |
Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins PH Tan, AA Thike, WJ Tan, MMM Thu, I Busmanis, HH Li, WY Chay, ... Journal of clinical pathology, jclinpath-2011-200368, 2011 | 358 | 2011 |
A molecular classification of papillary renal cell carcinoma XJ Yang, MH Tan, HL Kim, JA Ditlev, MW Betten, CE Png, EJ Kort, ... Cancer Research 65 (13), 5628-5637, 2005 | 273 | 2005 |
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma MH Tan, C Morrison, P Wang, X Yang, CJ Haven, C Zhang, P Zhao, ... Clinical cancer research 10 (19), 6629-6637, 2004 | 267 | 2004 |
Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database … N Kroeger, W Xie, JL Lee, GA Bjarnason, JJ Knox, MJ MacKenzie, ... Cancer 119 (16), 2999-3006, 2013 | 250 | 2013 |
Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection AKJ Teo, Y Choudhury, IB Tan, CY Cher, SH Chew, ZY Wan, LTE Cheng, ... Scientific Reports 11 (1), 1-8, 2021 | 162 | 2021 |
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy DY Heng, MJ Mackenzie, UN Vaishampayan, GA Bjarnason, JJ Knox, ... Annals of Oncology 23 (6), 1549-1555, 2011 | 156 | 2011 |
Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials DYC Heng, TK Choueiri, BI Rini, J Lee, T Yuasa, SK Pal, S Srinivas, ... Annals of Oncology 25 (1), 149-154, 2014 | 155 | 2014 |
Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives I Cima, C Wen Yee, FS Iliescu, W Min Phyo, K Hon Lim, C Iliescu, ... Biomicrofluidics 7 (1), 011810, 2013 | 150 | 2013 |
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study LC Harshman, W Xie, GA Bjarnason, JJ Knox, M MacKenzie, L Wood, ... The Lancet Oncology 13 (9), 927-935, 2012 | 144 | 2012 |
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma B Gardie, A Remenieras, D Kattygnarath, J Bombled, S Lefèvre, ... Journal of medical genetics 48 (4), 226-234, 2011 | 137 | 2011 |
Tumor-derived circulating endothelial cell clusters in colorectal cancer I Cima, SL Kong, D Sengupta, IB Tan, WM Phyo, D Lee, M Hu, C Iliescu, ... Science Translational Medicine 8 (345), 345ra89-345ra89, 2016 | 128 | 2016 |
Prognostic factors in patients with diffuse large B cell lymphoma: before and after the introduction of rituximab L Ngo, SW Hee, LC Lim, M Tao, R Quek, SP Yap, EL Loong, I Sng, ... Leukemia & lymphoma 49 (3), 462-469, 2008 | 125 | 2008 |
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype CJ Haven, VM Howell, PHC Eilers, R Dunne, M Takahashi, ... Cancer research 64 (20), 7405-7411, 2004 | 125 | 2004 |